Clinicians must exercise extreme caution when administering the antifibrinolytic drug to prevent life-threatening mix-ups ...
The European Medicines Agency’s Pharmacovigilance Risk Committee (PRAC) has agreed on a direct healthcare professional communication (DHPC) to remind healthcare professionals that extreme caution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback